Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Cells
|
June 21, 2020
Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies
Katie Healy, Anna Pasetto, Michał J Sobkowiak, et al.
Journal of Virology
|
February 24, 2017
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties
Anangi Balasiddaiah, Haleh Davanian, Soo Aleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 4, 2013
A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice
Fredrik Holmström, Anna Pasetto, Veronica Nähr, et al.
The Journal of General Virology
|
November 11, 2011
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
Anna Pasetto, Lars Frelin, Anette Brass, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
Drew C Deniger, Anna Pasetto, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity
Anna Pasetto, Lars Frelin, Soo Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2017
A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Drew C Deniger, Mei Li M Kwong, Anna Pasetto, et al.
Plos One
|
June 21, 2013
The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon
Maria L Knudsen, Daniel X Johansson, Linda Kostic, et al.
JCI Insight
|
October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
Rami Yossef, Eric Tran, Drew C Deniger, et al.
The Journal of Infectious Diseases
|
January 30, 2020
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
Panagiota Maravelia, Lars Frelin, Yi Ni, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Cells
|
June 21, 2020
Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies
Katie Healy, Anna Pasetto, Michał J Sobkowiak, et al.
Journal of Virology
|
February 24, 2017
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties
Anangi Balasiddaiah, Haleh Davanian, Soo Aleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 4, 2013
A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice
Fredrik Holmström, Anna Pasetto, Veronica Nähr, et al.
The Journal of General Virology
|
November 11, 2011
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
Anna Pasetto, Lars Frelin, Anette Brass, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
Drew C Deniger, Anna Pasetto, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity
Anna Pasetto, Lars Frelin, Soo Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2017
A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Drew C Deniger, Mei Li M Kwong, Anna Pasetto, et al.
Plos One
|
June 21, 2013
The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon
Maria L Knudsen, Daniel X Johansson, Linda Kostic, et al.
JCI Insight
|
October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
Rami Yossef, Eric Tran, Drew C Deniger, et al.
The Journal of Infectious Diseases
|
January 30, 2020
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
Panagiota Maravelia, Lars Frelin, Yi Ni, et al.
Page
of 5